EUVIMEDSkopri EUVIMED
Crossref

OTUB2 promotes the progression of endometrial cancer by regulating the PKM2‐mediated PI3K/AKT signaling pathway

Qian Zhang, Jing Zhang, Anmei Yao, Xiaofei Tian, Zhihong Han, Yuan Yuan, Kai Tao, Xuemei Yang

Cell Biology International · 2023-02 · 47 (2) · 428-438

DOI: 10.1002/cbin.11950 ↗

At a glance

Journal article in Cell Biology International, published online on 2022-10-31. Written by Qian Zhang and 7 co-authors. Institution: Department of The First of Internal Medicine, Shaanxi Provincial Cancer Hospital, Xi'an, Shannxi, People's Republic of China. Major MEDLINE topics: Proto-Oncogene Proteins c-akt, Endometrial Neoplasms. Cited 13 times so far (Crossref); 29 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Endometrial carcinoma (EC) morbidity and mortality have been increasing in recent years. Otubain 2 (OTUB2) was shown to be upregulated in EC patients, so the aim of this study was to explore the role of OTUB2 in EC. Cell Counting Kit‐8 (CCK‐8), colony formation, enzyme‐linked immunosorbent assay, the wound healing assay, and Transwell invasion assays were used to investigate the specific role of OTUB2 in EC tumorigenesis. Real‐time polymerase chain reaction and western blot analysis were used to detect the expression of OTUB2 in EC tissues and cells. OTUB2 is upregulated in EC patients and cell lines and is associated with a poor prognosis. The overexpression of OTUB2 promoted glycolysis and induced the proliferation, migration, and invasion of endometrial cancer cells. The silencing of OTUB2 had the opposite effect. In addition, the silencing of OTUB2 significantly suppressed the expression levels of PKM2. Importantly, inhibition of the PKM2/PI3K/AKT signaling pathway significantly reversed the promoting effect of OTUB2 overexpression on EC. OTUB2 regulated the proliferation and invasion of EC cells by regulating the PKM2/PI3K/AKT signaling pathway. OTUB2 may serve as a potential prognostic and therapeutic target in EC.

Subjects

MeSH terms (MEDLINE)

Proto-Oncogene Proteins c-aktEndometrial NeoplasmsFemaleHumansPhosphatidylinositol 3-KinasesCell Line, TumorCell MovementSignal TransductionCell ProliferationGene Expression Regulation, NeoplasticThiolester Hydrolases

Author keywords

OTUB2PKM2/PI3K/AKTendometrial carcinomaglycolysisinvasion

Substances

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesOTUB2 protein, humanThiolester Hydrolases

Authors and institutions

  • Department of The First of Internal Medicine, Shaanxi Provincial Cancer Hospital, Xi'an, Shannxi, People's Republic of China.
  • Department of The Fourth of Gynecologic Oncology, Shaanxi Provincial Cancer Hospital, Xi'an, Shannxi, People's Republic of China.
  • Department of The Second of Gynecologic Oncology, Shaanxi Provincial Cancer Hospital, Xi'an, Shannxi, People's Republic of China.

Cite

APA

Zhang, Q., Zhang, J., Yao, A., Tian, X., Han, Z., Yuan, Y., Tao, K., & Yang, X. (2023). OTUB2 promotes the progression of endometrial cancer by regulating the PKM2‐mediated PI3K/AKT signaling pathway. Cell Biology International, 47(2), 428-438. https://doi.org/10.1002/cbin.11950

Vancouver

Zhang Q, Zhang J, Yao A, Tian X, Han Z, Yuan Y, et al. OTUB2 promotes the progression of endometrial cancer by regulating the PKM2‐mediated PI3K/AKT signaling pathway. Cell Biology International. 2023;47(2):428-438. doi:10.1002/cbin.11950

BibTeX
@article{Zhang2023,
  author = {Zhang, Qian and Zhang, Jing and Yao, Anmei and Tian, Xiaofei and Han, Zhihong and Yuan, Yuan and Tao, Kai and Yang, Xuemei},
  title = {OTUB2 promotes the progression of endometrial cancer by regulating the PKM2‐mediated PI3K/AKT signaling pathway},
  journal = {Cell Biology International},
  year = {2023},
  volume = {47},
  number = {2},
  pages = {428--438},
  doi = {10.1002/cbin.11950}
}
Start for free →